Latest advances in innate antiviral defence
ATF3 suppresses metastasis of bladder cancer by regulating gelsolin-mediated remodeling of the actin cytoskeleton.
Helicobacter pylori VacA suppresses Lactobacillus acidophilus-induced interferon beta signaling in macrophages via alterations in the endocytic pathway.
Sustained Low-Dose Treatment with the Histone Deacetylase Inhibitor LBH589 Induces Terminal Differentiation of Osteosarcoma Cells.
Regulation of Actin Dynamics by Protein Kinase R Control of Gelsolin Enforces Basal Innate Immune Defense
Analysis of microRNA turnover in mammalian cells following Dicer1 ablation
Rational design of immunostimulatory siRNAs
Genetic modulation of TLR8 response following bacterial phagocytosis
Future of RNAi-based therapies for human papillomavirus-associated cervical cancer
A novel method for screening viral interferon-resistance genes
BTB-ZF transcriptional regulator PLZF modifies chromatin to restrain inflammatory signaling programs
The immune receptor NOD1 and kinase RIP2 interact with bacterial peptidoglycan on early endosomes to promote autophagy and inflammatory signaling
Molecular dynamics reveal a novel kinase-substrate interface that regulates protein translation
ATF3 suppresses metastasis of bladder cancer by regulating gelsolin-mediated remodeling of the actin cytoskeleton
Helicobacter pylori VacA suppresses Lactobacillus acidophilus-induced interferon beta signaling in macrophages via alterations in the endocytic pathway
Sustained low-dose treatment with the Histone deacetylase inhibitor LBH589 induces terminal differentiation of osteosarcoma cells
The development and future of oligonucleotide-based therapies for cervical cancer
The acetyltransferase HAT1 moderates the NF-κB response by regulating the transcription factor PLZF